Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Monday morning. The brokerage issued a sell rating on the stock. Several other analysts have also recently commented on ONCT. HC Wainwright upgraded shares of Oncternal Therapeutics from a neutral rating to a buy rating and set […]

Related Keywords

,Mirabella Financial Services ,Richmond Brothers Inc ,Prudential Financial Inc ,Oncternal Therapeutics Inc ,Oncternal Therapeutics Company Profile ,Pasadena Private Wealth ,Cantor Fitzgerald ,Virtu Financial ,Oncternal Therapeutics ,Free Report ,Therapeutics Trading Down ,Get Free Report ,Financial Services ,Orphan Receptor ,Oncternal Therapeutics Daily ,Nasdaq Onct ,Conct ,Medical ,Initiated Coverage ,Stocknews Com ,